Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people should expect to take semaglutide for weight management over the long term, not just a few months. Clinical evidence and UK prescribing guidance both point to sustained treatment being the key to lasting results — with NICE recommending use for up to two years within a specialist service, and ongoing prescribing remaining an option where it is clinically appropriate. These are prescription-only medicines, so how long you stay on semaglutide is always a decision made with a prescriber rather than a fixed rule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most persistent misunderstanding about semaglutide is that it works like an antibiotic, take it for a defined period, achieve the result, and you're done. That is not how the medicine works. Semaglutide acts on GLP-1 receptors to reduce appetite, slow gastric emptying and support blood-sugar regulation. All of those effects are active while you are on the medicine. When you stop, they stop too.
The STEP 1 trial (a large phase-3 study published in the New England Journal of Medicine) found that participants who discontinued semaglutide regained around two-thirds of the weight they had lost within a year. That figure is not a criticism of the medicine; it is a description of how the biology works. Obesity is a chronic condition, and effective treatment for a chronic condition tends to be ongoing.
A question our prescribers hear most weeks is some version of: "If I lose enough weight, can I come off it?" The honest answer is that some people do reduce or stop successfully, particularly when lifestyle changes are genuinely embedded. But that is a clinical conversation, not a milestone you hit automatically at month six.
For practical detail on how duration plays out in the real world, our page on how long you should be on Wegovy covers the question from several angles.
NICE recommended Wegovy (semaglutide 2.4 mg injection) for weight management in TA875, published in March 2023. Crucially, that recommendation includes a maximum treatment duration of two years within a specialist weight management service, and adds that treatment should be reviewed and potentially stopped if less than 5% of body weight has been lost after six months on the maintenance dose.
That two-year ceiling is specific to the NHS access route through specialist services. Private prescribing follows the licensed indication, the SmPC, and the prescriber's clinical judgement, there is no hard private-sector cut-off at 24 months, but responsible prescribers review ongoing treatment regularly. The NICE appraisal of semaglutide (TA875) is the definitive reference for understanding how NHS treatment duration is defined.
It is also worth knowing that the titration period forms part of your overall treatment timeline. Starting at 0.25 mg and working up to the 2.4 mg maintenance dose takes around four months; if you are wondering how long you should take Wegovy, it helps to understand that the weight-loss results trials report at 68 weeks include that ramp-up phase, not just the time at the highest dose. To understand how long results typically take to appear, the page on how long Wegovy takes to work sets out realistic timelines in more detail.
Stopping semaglutide is safe when done with clinical input, but the timing and circumstances matter. The NHS England guidance on weight management injections highlights that stopping suddenly without a plan for sustaining behaviour changes is strongly associated with weight regain. Appetite returns to its previous level, often sharply, once the medicine is out of your system.
If your prescriber agrees it is the right time to stop, that conversation should include a clear picture of the diet and activity patterns you have built, any other health conditions that were being managed alongside weight, and how you will monitor things over the months that follow. Stopping is not failure; stopping without preparation tends to undo the work.
There are also situations where pausing or stopping is necessary for other clinical reasons, planned surgery, pregnancy planning, certain medication interactions. On that last point, it is worth reading our page on whether you can stop Wegovy at any time, which covers the practicalities clearly. Pregnancy is a particular consideration: semaglutide is not recommended during pregnancy, breastfeeding, or while actively trying to conceive, and a wash-out period is advised before conception.
For a broader look at the Wegovy injection and what treatment involves, the Wegovy treatment overview is a good starting point. And if you are thinking about whether private treatment might be the right route given NHS eligibility timelines, the weight loss treatment options page explains what is available through nume. Our guide on how long you should take semaglutide is also worth reading before your next review, as duration of treatment and ongoing suitability are assessed by our prescribers before every repeat, there are no automatic renewals.
If you want to explore whether semaglutide is clinically appropriate for you, check your eligibility through a free consultation with our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.